Targeting IL-6 receptor mediated metabolic pathways to control Th17 cell differentiation and inflammatory responses.
August 27, 2025
Alwarawrah Y, Nichols AG, Patel I, Ball AB, MacIver NJ. Front Immunol. 2025 Aug 27;16:1568514. doi: 10.3389/fimmu.2025.1568514. PMID: 40936905; PMCID: PMC12420212.